Facebook Pixel image HerculesKabuterimon (X Antibody) BT11-058 | Digimon digimon Cards

digimon > Cards > HerculesKabuterimon (X Antibody) BT11-058

HerculesKabuterimon (X Antibody) BT11-058 image
set min mtgo
- A$ 0.00 0.0 tix
Icons of mtg
Name HerculesKabuterimon (X Antibody) BT11-058 Edit card
Type Digimon - mega vaccine insectoid/x antibody
Description Effect Digivolve: 1 from [HerculesKabuterimon]<Security Attack +1> (This Digimon checks 1 additional security card.)[When Digivolving] If this Digimon has [HerculesKabuterimon] or [X Antibody] in its digivolution cards, return 1 of your opponent's suSee more
Artist Digimon Card Game
Set Digimon card game dimensional phase [bt11] #BT11-058
Wallpaper HerculesKabuterimon (X Antibody) BT11-058 Crop image Wallpaper download
Image HerculesKabuterimon (X Antibody) BT11-058 Full hd image download
⚠️

Tierlist

No Rank

Grade it yourself

Meta types

Edit card

Legality between formats

Edit card

About HerculesKabuterimon (X Antibody) BT11-058

HerculesKabuterimon (X Antibody) BT11-058, Digimon - mega vaccine insectoid/x antibody, designed by Digimon Card Game first released in Jul, 2024 in the set Dimensional Phase.

This HerculesKabuterimon (X Antibody) Digimon Card would benefit a deck focused on aggressive plays and disrupting the opponent's board state. Its ability to return a suspended Digimon to the bottom of the opponent's deck upon digivolving can be a powerful disruption tactic. While there may be other cards with different effects that could be more versatile in certain situations, this card's unique ability can be strategically valuable and could see play in decks looking to control the game tempo and apply pressure consistently.

Where to buy

Seller image Ebay.com

Visit store
Seller image Printing proxies

$ 0.75 Visit store

*This site contains affiliate links for which we may be compensated

Group by

Price alert ?

Alert me when price gets to

Price trend history

loading
Profile imageSign in and join the conversation

— Comments0

User profile image

Be the first to comment